FIBROGEN
Live / Registered — Registered (as of 17 Aug 2021)
What this means for you
Registered since 17 Aug 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90328258
- Registration number
- 6455210
- Mark type
- Stylized text
- Filed
- 18 Nov 2020
- Published for opposition
- 01 Jun 2021
- Registered
- 17 Aug 2021
- Attorney of record
- Harold Milstein
Goods and services
- Class 001 — Chemicals: Connective Tissue Growth Factor (CTGF) and anti-connective tissue growth factor antibodies for research and diagnostic use; prolyl hydroxylase inhibitors for research use
- Class 005 — Pharmaceuticals: Connective Tissue Growth Factor (CTGF) and anti-connective tissue growth factor antibodies for clinical and pharmaceutical use; prolyl hydroxylase inhibitors for clinical or pharmaceutical use
Owner
- FibroGen, Inc., San Francisco, CA, US
- FibroGen, Inc., San Francisco, CA, US
- FibroGen, Inc., San Francisco, CA, US
Prior registrations
Prosecution history
- 07 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 01 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jun 2021 — PUBLISHED FOR OPPOSITION
- 12 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Apr 2021 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 29 Apr 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Apr 2021 — USE AMENDMENT ACCEPTED